Med Sci Monit 13(1): CR30-CR33
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Following this regimen, a comprehensive evaluation of hepatic, renal, and myocardial toxicity was conducted
In the UK multicenter randomized placebo-controlled trial, no subgroup stratified by baseline BMI demonstrated a greater likelihood of responding to Exenatide relative to the rest of the study population [34]
That all changed from my very first appointment
10.1007/s00125-013-2856-6 88 HuP.YinQ.DeckertF.JiangJ.LiuD.KjemsL.et al (2009)
